Randomized Controlled Trial
Copyright ©The Author(s) 2025.
World J Hepatol. Jan 27, 2025; 17(1): 101704
Published online Jan 27, 2025. doi: 10.4254/wjh.v17.i1.101704
Table 5 Biochemical parameters at baseline and at weeks 12 and 24 in the control group with metabolic dysfunction-associated steatotic liver disease
Biochemical parameters
Baseline
12 weeks
24 weeks
P value
Leukocytes in thousands/μL16.6 (4.1-9.5)6.3 (4-9.6)7.7 (4.2-9.9)0.050
Hb in g/dL213.1 + 1.413.0 + 1.312.9 + 2.30.071
Platelets in miles/μL2278 + 73254 + 59251 + 500.107
TB in mg/dL20.52 + 0.320.65 + 0.400.72 + 0.330.001
AST in U/L124 (12-148)29 (18-110)25 (17-75)0.185
ALT in U/L130 (10-137)30 (15-97)28 (18-86)0.644
ALP in IU/L2101 + 4186 + 3038 + 180.011
GGT in U/L136 (19-198)26 (11-152)72 (28-98)0.160
TP in g/dL17.3 (6.3-8.8)7.4 (6.6-8.8)7.7 (6.7-8.9)0.661
Albumin in g/dL24.00 + 0.574.20 + 0.597.50 + 0.520.056
Cholesterol in mg/dL2195 + 51203 + 39185 + 390.457
    HDL in mg/dL144 (23-66)44 (32-70)48 (27-95)0.213
    LDL in mg/dL2125 + 53128 + 37110 + 350.425
    VLDL in mg/dL231.0 + 14.029.0 + 10.027.0 + 9.60.041
Triglycerides in mg/dL2151 + 67145 + 51138 + 480.116
Glucose in mg/dL1104 (71-175)91 (81-148)108 (90-177)0.332
Creatinine in mg/dL20.76 + 0.210.66 + 0.130.69 + 0.200.233
CRP in mg/L12.70 (0.40-1.45)0.80 (0.70-0.90)0.27 (0.03-3.10)0.018
Insulin in mg/L28.8 + 6.720.0 + 10.015.9 + 6.20.015
HOMA25.6 + 4.65.1 + 3.04.1 + 1.90.497